BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26917409)

  • 1. Hospital discharge records as data source to monitor epidemiologic indicators of hematologic malignancies in Abruzzo.
    Vitullo F; Di Biagio K; Murgano A; Di Bartolomeo P
    Tumori; 2016 Jun; 2016(3):258-63. PubMed ID: 26917409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.
    Elidrissi Errahhali M; Elidrissi Errahhali M; Boulouiz R; Ouarzane M; Bellaoui M
    BMC Cancer; 2016 Feb; 16():159. PubMed ID: 26915519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
    Pulte D; Jansen L; Brenner H
    Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematological malignancies in the island of Sardinia, 1974-1993: age and sex distributions and temporal changes in incidence.
    Broccia G; Deplano W; Dessalvi P; Giannico B; Luxi G; Chessa E; Murru A
    Hematol Oncol; 2004 Sep; 22(3):91-109. PubMed ID: 15991220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
    Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
    Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
    Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
    Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
    Pulte D; Gondos A; Brenner H
    Cancer; 2009 Nov; 115(21):4973-9. PubMed ID: 19705347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthropometric characteristics, physical activity and risk of hematological malignancies: A systematic review and meta-analysis of cohort studies.
    Psaltopoulou T; Sergentanis TN; Ntanasis-Stathopoulos I; Tzanninis IG; Riza E; Dimopoulos MA
    Int J Cancer; 2019 Jul; 145(2):347-359. PubMed ID: 30614529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohort.
    Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
    Int J Cancer; 2021 Jan; 148(2):375-384. PubMed ID: 32683691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of bacteremia among histologic groups of hematologic malignancies].
    Teira R; Lizarralde E; Santamaría JM; Zubero Z; Muñoz P; Baraiaetxaburu J; Olabarría I; Ezpeleta C; Beltrán de Heredia JM; Cisterna R
    Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):24-9. PubMed ID: 12550041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
    Ocias LF; Larsen TS; Vestergaard H; Friis LS; Abildgaard N; Frederiksen H;
    Acta Oncol; 2016; 55 Suppl 1():98-107. PubMed ID: 26783877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of patients with hematological malignancies at gondar university hospital, North West Ethiopia.
    Weldetsadik AT
    Ethiop Med J; 2013 Jan; 51(1):25-31. PubMed ID: 23930488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-AIDS-defining hematological malignancies in HIV-infected patients: an epidemiological study in Japan.
    Hagiwara S; Yotsumoto M; Odawara T; Ajisawa A; Uehira T; Nagai H; Tanuma J; Okada S
    AIDS; 2013 Jan; 27(2):279-83. PubMed ID: 23014520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.
    Sant M; Allemani C; Tereanu C; De Angelis R; Capocaccia R; Visser O; Marcos-Gragera R; Maynadié M; Simonetti A; Lutz JM; Berrino F;
    Blood; 2010 Nov; 116(19):3724-34. PubMed ID: 20664057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synchronous and metachronous myeloid and lymphoid tumors].
    Melikian AL; Kolosheĭnova TI; Goriacheva SR; Subortseva IN; Vakhrusheva MV; Kolosova EN; Sudarikov AB; Abdullaev AO; Dvirnyk VN; Varlamova EIu; Kovrigina AM; Turkina AG
    Ter Arkh; 2014; 86(7):37-44. PubMed ID: 25314776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.